A novel array-based nanozyme aptasensing platform has achieved 100% accuracy in classifying different strains of Staphylococcus aureus (S. aureus).
Study: Nanozyme Aptasensor Array for Predictive Sensing of Virulent and Antibiotic-Resistant Staphylococcus Aureus strains. Image Credit: Dabarti CGI/Shutterstock.com
S. aureus is a significant global health threat, causing over a million infection-related deaths each year. The rise of antibiotic-resistant strains, particularly methicillin-resistant S. aureus (MRSA), has heightened the need for rapid, accurate diagnostics.
A recent study published in Small introduced a platform for strain-level detection, enabling fast identification of pathogenic and resistant strains. This system uses the combined properties of nanozymes and aptamers, making it a valuable tool for clinical diagnostics.
Transforming Diagnostics with Nanotechnology
The emergence of antibiotic-resistant bacteria has intensified the demand for rapid diagnostic tools. Traditional methods, while effective, are often slow, limiting their clinical application. In contrast, nanotechnology has enabled faster pathogen detection.
The nanozyme aptasensor technology uses gold nanoparticles (GNPs) that exhibit enzyme-like catalytic activity, known as nanozymes. These nanozymes mimic natural enzymes while offering enhanced stability and lower costs, supporting simple detection.
Aptamers, short single-stranded nucleic acids, serve as selective recognition elements that bind to target pathogens. When combined with nanozymes, they provide high specificity and sensitivity in detection. The integration of nanozymes with aptamers creates a robust sensing platform capable of strain-level detection of S. aureus, thereby enabling distinct colorimetric responses for different strains.
Methodology: Developing the Colorimetric Sensor Array
Researchers developed a colorimetric nanozyme aptasensor array for detecting multiple strains of S. aureus. Citrate-functionalized GNPs were synthesized using the Turkevich method and purified to remove unreacted gold ions. The nanoparticles were then characterized using material analysis techniques to confirm their properties.
To construct the sensor probes, a fixed concentration of four aptamers (SA20, SA23, SA31, and SA43) was incubated with the GNPs. The binding of these aptamers to the nanoparticle surface temporarily suppressed the nanoparticle’s inherent nanozyme activity. The catalytic activity was evaluated through a peroxidase-like assay by monitoring the oxidation of 3,3′,5,5′-tetramethylbenzidine (TMB) in the presence of hydrogen peroxide.
Biosensing experiments were conducted using different S. aureus strains and other pathogens to assess specificity and sensitivity. When the target bacteria interacted with aptamer-functionalized GNPs, nanozyme activity was restored, resulting in distinct colorimetric responses. The resulting response patterns were analyzed using hierarchical clustering analysis (HCA) and linear discriminant analysis (LDA), enabling accurate classification of different strains based on their unique colorimetric fingerprints.
Key Findings: Distinguishing S. aureus Strains
The nanozyme aptasensor array effectively distinguished between different S. aureus strains, including MRSA variants. The multi-aptamer design was improved, enabling the sensor to capture subtle phenotypic differences in virulence and antibiotic resistance.
Each strain produced a distinct colorimetric response, generating unique fingerprints for accurate identification. Machine learning analysis enhanced classification performance by interpreting complex response patterns. The model achieved 100 % accuracy in cross-validation, confirming the robustness and reliability of the sensing platform.
Want to save for later? Click here.
The sensor exhibited high selectivity, showing minimal response to non-target pathogens, and demonstrated sensitivity with detectable signals at concentrations as low as 100 cells per milliliter. This low detection limit emphasizes its suitability for early clinical diagnosis.
Practical Applications: A Versatile Diagnostic Tool
The implications of this research extend beyond S. aureus detection. The nanozyme aptasensor array offers a versatile platform that can be modified to detect other clinically relevant pathogens by integrating different target-specific aptamers.
Its rapid response, low cost, and minimal need for complex laboratory infrastructure make it a practical alternative to conventional methods such as PCR and culture-based assays.
This platform can serve as a screening tool in hospitals, clinics, and resource-limited settings where timely diagnosis is critical. By enabling strain-level identification and providing insights into virulence and antibiotic resistance profiles, it supports informed treatment decisions.
Furthermore, integrating machine learning with sensor output enhances its ability to recognize emerging strains and evolving infection patterns. This adaptability strengthens its potential role in infectious disease surveillance and early diagnosis.
Advancing Diagnostic Technologies
The study demonstrates that the nanozyme aptasensor array represents a significant advancement in rapid pathogen detection. The platform enables accurate, strain-level identification of S. aureus through distinct colorimetric fingerprints, supporting faster diagnostics. By combining nanozymes and aptamers, the system overcomes key limitations of traditional methods, particularly in terms of speed, cost, and sensitivity.
The findings highlight the potential to improve clinical decision-making, particularly in managing antibiotic-resistant infections. Rapid identification of virulent and resistant strains can facilitate timely treatment and better infection control. This approach underscores the role of nanotechnology and biosensing in modern healthcare diagnostics.
Overall, this research provides a solid foundation for future biosensing innovations. Further refinement and expansion of the sensor platform could enable the detection of a wider range of pathogens, strengthening disease surveillance and public health response.
Journal Reference
W, Pabudi. et al. (2026). Nanozyme Aptasensor Array for Predictive Sensing of Virulent and Antibiotic-Resistant Staphylococcus Aureus strains. Small, e12266. DOI: 10.1002/smll.202512266, https://onlinelibrary.wiley.com/doi/10.1002/smll.202512266
Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.